US 11304996
Yeast-based immunotherapy and type I interferon sensitivity
granted A61KA61K2039/52A61K2039/57
Quick answer
US patent 11304996 (Yeast-based immunotherapy and type I interferon sensitivity) held by The Regents of the University of Colorado, a Body Corporate expires Mon Apr 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado, a Body Corporate
- Grant date
- Tue Apr 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K2039/52, A61K2039/57, A61K36/064, A61K39/0011